Tag Archive for: exact therapeutics

EXACT Therapeutics AS Announces Allowance of Patent Application in Europe for Acoustic Cluster Therapy (ACT®)

/in

OSLO/LONDON, 22 December 2021: Christmas came early at EXACT Therapeutics AS (“EXACT-Tx”, or “the Company”, Euronext Growth: EXTX) as the clinical-stage precision health company developing the proprietary ultrasound-mediated drug delivery platform Acoustic Cluster Therapy (ACT®) for use across multiple diseases, announces today that allowability has been found for its patent application in Europe (publication no. EP3049117) for its innovative Acoustic Cluster […]

Read more

EXACT Therapeutics AS to present at DNB Nordic Healthcare Conference on 16th December 2021

/in

OSLO/LONDON: 13 DECEMBER, 2021: EXACT Therapeutics AS (“EXACT-Tx”, or “the Company” Euronext Growth: EXTX), a clinical-stage precision health company evaluating Acoustic Cluster Therapy (ACT®) across multiple therapeutic areas, today announces that its Interim Chief Executive Officer and Chief Financial Officer, Dominic Moreland and Chief Medical Officer, Dr Hilary McElwaine-Johnn will present a corporate overview via […]

Read more

Exact Therapeutics AS Appoints Prominent Ultrasound And Healthcare Expert To Its Board Of Directors

/in

Underscores the Company’s ambition to harness the power of ultrasound in precision therapeutics amplification. OSLO/LONDON: 6 DECEMBER, 2021: Exact Therapeutics AS (“EXACT-Tx”, or “the Company” Euronext Growth: EXTX), a clinical-stage precision health company evaluating Acoustic Cluster Therapy (ACT®) across multiple therapeutic areas, today is delighted to announce the appointment of Anders Wold to its Board […]

Read more